← stocks-llm Find companies like LNTH →

LANTHEUS HOLDINGS INC (LNTH)

Health Care · Radiopharmaceuticals and diagnostic imaging agents · NASDAQ

Lantheus is a radiopharmaceutical company producing nuclear imaging agents and ultrasound contrast agents for oncology, cardiology, and neurology diagnostics.

What LANTHEUS HOLDINGS INC does

Lantheus Holdings is a pharmaceutical company specializing in radiopharmaceuticals and imaging agents used for diagnostic imaging across multiple medical specialties. The company develops and commercializes products for nuclear medicine imaging (including PET and SPECT imaging), ultrasound contrast agents, and therapeutic radiopharmaceuticals. Lantheus serves hospitals, imaging centers, and diagnostic facilities worldwide through its own manufacturing facilities and third-party partnerships, with a focus on oncology, cardiology, and neurology applications.

Themes: ["oncology imaging","PET/SPECT imaging","prostate cancer diagnostics","cardiac ultrasound contrast","neurodegenerative disease imaging","Alzheimer's disease diagnostics","neuroendocrine tumor imaging","diagnostic radiopharmaceuticals"]

Fundamentals

Ask why LNTH looks like this →

Key risks (from latest filing)

["Dependence on FDA approval for new product candidates including F-18 PSMA and LNTH-2501; delays or denials could materially impact revenue growth","Supply chain vulnerability for raw materials, manufacturing equipment, and key components including PET scanners; shortages could constrain product availability and revenue","Competition from larger pharmaceutical and diagnostics companies with greater resources for R&D, manufacturing scale, and market penetration"]

See LNTH's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.